Home  >  Products  >  FGF8 (fibroblast growth factor 8 (androgen-induced) ) Blocking Peptide (the C terminal of FGF8)(100ug)
FGF8 (fibroblast growth factor 8 (androgen-induced) ) Blocking Peptide (the C terminal of FGF8)(100ug)

FGF8 (fibroblast growth factor 8 (androgen-induced) ) Blocking Peptide (the C terminal of FGF8)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-FGF8 Antibody (ARP63185_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63185
Size: 100ug
Weight: 22kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein is known to be a factor that supports androgen and anchorage independent growth of mammary tumor cells. Overexpression of this gene has been shown to increase tumor growth and angiogensis. The adult expression of this gene is restricted to testes and ovaries. Temporal and spatial pattern of this gene expression suggests its function as an embryonic epithelial factor. Studies of the mouse and chick homologs revealed roles in midbrain and limb development, organogenesis, embryo gastrulation and left-right axis determination. The alternative splicing of this gene results in four transcript variants.
Alternative names: AIGF; HBGF-8; KAL6; MGC149376
See Full Product Listings >